Another mechanism explaining this observed down-regulation of NK cell activating receptors could be due to the transfer of NK cell receptors between tumor cells after immune cell–tumor cell contact, as we have observed for CB-NK and MM cells. The gene discussed is KLRD1; the disease is Miyoshi myopathy.